Syneos Health Releases the 2019 Health Trend Ten, Outlining Critical Shifts Impacting Drug Development and Commercialization
27 nov. 2018 10h15 HE
|
Syneos Health
RALEIGH, N.C., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released a trends forecast outlining critical...
CureVac to Present at the 19th Annual Piper Jaffray Healthcare Conference
21 nov. 2018 07h00 HE
|
CureVac AG
TÜBINGEN, Germany and BOSTON, Nov. 21, 2018 (GLOBE NEWSWIRE) -- CureVac AG, a fully integrated biopharmaceutical company pioneering the field of mRNA-based drugs, today announced that Dan...
Aslan Pharmaceuticals to Participate in 30th Annual Piper Jaffray Healthcare Conference
20 nov. 2018 05h00 HE
|
ASLAN Pharmaceuticals Limited
SINGAPORE, Nov. 20, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (NASDAQ:ASLN, TPEx:6497), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and...
Biofrontera reports earnings results for the third quarter and first nine months of 2018
16 nov. 2018 02h20 HE
|
Biofrontera AG
Leverkusen, Germany, Nov. 16, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its...
EXL Partnering with PharmaCord to improve biopharmaceutical patient support programs through advanced analytics
13 nov. 2018 08h30 HE
|
ExlService Holdings, Inc.
NEW YORK, Nov. 13, 2018 (GLOBE NEWSWIRE) -- EXL (NASDAQ: EXLS), a leading operations management and analytics company, today announced that it is pursuing a go-to-market strategy with PharmaCord,...
Biofrontera Announces Conference Call to Discuss Q3 2018 Financial Results
05 nov. 2018 06h26 HE
|
Biofrontera AG
Leverkusen, Germany, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be releasing its...
Syneos Health Wins Society for Clinical Research Sites Eagle Award for Second Consecutive Year
15 oct. 2018 10h45 HE
|
Syneos Health
Investigative Sites Recognize Company’s Leadership in Advancing Clinical Research Through Collaborative Site Relationships RALEIGH, N.C., Oct. 15, 2018 (GLOBE NEWSWIRE) -- Syneos HealthTM...
Nemus Bioscience Announces that Emerald Health Sciences has Provided a Credit Facility of up to $20 Million and Adopted an Open Market Share Purchase Program of up to 10 Million Common Shares
08 oct. 2018 08h00 HE
|
Nemus Bioscience, Inc.
Avtar Dhillon, MD, appointed as Executive Chairman of Nemus LONG BEACH, CA, Oct. 08, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Nemus Bioscience, Inc. (OTCQB: NMUS), focused on the...
VBI Vaccines to Present at the Ladenburg Thalmann 2018 Healthcare Conference
27 sept. 2018 08h00 HE
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., Sept. 27, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (NASDAQ: VBIV) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and...
NEMUS Bioscience to Present at The MicroCap Conference
26 sept. 2018 08h00 HE
|
Nemus Bioscience, Inc.
LONG BEACH, CA, Sept. 26, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - NEMUS Bioscience, Inc. (OTCQB: NMUS), focused on the development of cannabinoid-based therapeutics to address global medical...